Condition
Binge Eating Behaviour
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07024550Not ApplicableActive Not RecruitingPrimary
Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway
NCT07217847Not ApplicableNot Yet Recruiting
Testing SHAPE: A Single-Session Intervention Targeting Binge Eating in Women Through Assessment and Values-Based Strategies
NCT07143214Not ApplicableCompleted
Wise Eating: A Guided Digital DBT-Based Intervention for Binge Eating
NCT01739049Phase 4CompletedPrimary
Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
Showing all 4 trials